Company profile: BioDot
1.1 - Company Overview
Company description
- Provider of automated low-volume, non-contact quantitative fluid dispensing systems and lamination, cutting, and assembly expertise. Platforms enable direct dispensing of lines and dots on membranes, papers, microwell plates, slides, and microfluidics, plus web handling and dip coating from roll stock and auto lamination, serving R&D through high-volume manufacturing in industrial, diagnostic, life science, and medical markets.
Products and services
- AD3220 Aspirate Dispense System: Quantitative platform aspirating and directly dispensing lines and dots on microwell plates, slides, microfluidics, and custom labware
- ZX1010 Dispense System: Non-contact system directly dispensing lines and dots onto membranes, papers, custom devices for low-volume precision in R&D and manufacturing
- RR120 Web Handling System: Roll-stock platform delivering direct dispensing and dip coating on membranes and papers from roll stock for web handling operations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioDot
A4Cell
HQ: Spain
Website
- Description: Provider of SPAchip technology using intracellular silicon microchips to monitor living single cells and cellular pathways in real time without affecting viability. Offers kits: CytoCHECK pH Green, pH Red, Calcium; CytoTRACK pH Dual-Detection; and SpheroCHECK pH Green for 3D spheroids, enabling precise single-cell physiology monitoring to improve cell study data for understanding disease behavior.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full A4Cell company profile →
NuAire
HQ: United States
Website
- Description: Provider of ergonomic laboratory equipment for Life Science, Clinical, and Industrial research applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NuAire company profile →
LexaGene
HQ: United States
Website
- Description: Provider of molecular diagnostic systems for detecting pathogens and other molecular markers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LexaGene company profile →
Ionpath
HQ: United States
Website
- Description: Provider of ion beam–based multiplexed tissue imaging and spatial proteomics solutions, including the MIBIscope system with instrumentation, validated reagents, and visualization software; MIBI technology imaging 40+ protein markers per scan; MIBIplus single-cell analysis detecting 50+ phenotypes; Spatial Proteomic Services for segmentation, classification, and spatial analysis; and conjugated antibodies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ionpath company profile →
Peloton Therapeutics
HQ: United States
Website
- Description: Provider of cancer drug discovery and development based in Dallas. Offers a clinical-stage small-molecule HIF-2α inhibitor targeting hypoxia-inducible factor-2α for kidney cancer and other disorders, and research programs to discover compounds that modulate disease-driving protein-protein interactions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peloton Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioDot
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioDot
2.2 - Growth funds investing in similar companies to BioDot
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioDot
4.2 - Public trading comparable groups for BioDot
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →